期刊文献+

AnnexinⅠ在鼻咽癌中的表达及意义 被引量:1

Expression and Significance of AnnexinⅠin Nasopharyngeal Carcinoma
下载PDF
导出
摘要 目的:AnnexinⅠ是钙磷脂结合蛋白家族的一员,探讨AnnexinⅠ在慢性鼻咽炎、鼻咽癌组织中的表达及与鼻咽癌多项临床病理特征的关系。方法:采用免疫组织化学SABC法检测Annexin I在慢性鼻咽炎、鼻咽癌组织中的表达。结果:①Annexin I在鼻咽癌组织中的阳性表达率为29.55%,明显低于其在慢性鼻咽炎组织中的阳性表达率93.33%,差异具有显著性(P<0.01)。②Annexin Ⅰ的表达与鼻咽癌的组织分化程度有关(P<0.01),与临床分期、颅神经侵犯、颈淋巴结转移无相关性(P>0.05)。结论:AnnexinⅠ在鼻咽癌中的表达明显下调,鼻咽癌中Annexin I的表达与组织分化程度密切相关,Annexin I可能与鼻咽癌的发生发展有关。 Objective: AnnexinⅠis a member of the calcium and phospholipid-binding proteins superfamily.The purpose of this study was to investigate the expression of AnnexinⅠin chronic nasopharygitis and nasopharyngeal carcinoma,and the correlation between the expression of AnnexinⅠand the clinical pathological features of nasopharyngeal carcinoma.Method: The expression of Annexin I were detected using immunohistochemical staining(SABC).Result: ①The AnnexinⅠlabeling frequency(29.55%) in nasopharyngeal carcinoma was significantly lower than that(93.33%) in chronic nasopharyngitis group(P 〈 0.01),②AnnexinⅠexpression in nasopharyngeal carcinoma was correlated with histological grade(P 〈 0.01),but not correlated with clinical stage,cranial nerve encroaching and lymph node metastases(P 〉 0.05).Conclusion: The expression of AnnexinⅠis obviously down-regulated in human nasopharyngeal carcinoma and its expression is related with the histological differentiation status of human nasopharyngeal carcinoma,It is suggested that AnnexinⅠmay be involved in the development of human nasopharyngeal carcinoma.
出处 《河北医学》 CAS 2011年第3期311-315,共5页 Hebei Medicine
关键词 鼻咽癌 ANNEXIN 免疫组化 Nasopharyngeal carcinoma Annexin Ⅰ Immunohistochemistry
  • 相关文献

参考文献14

  • 1黄选兆 汪吉宝.实用耳鼻咽喉科学[M].北京:人民卫生出版社,1999.136.
  • 2Gerke V, Moss S. Annexins from structure to function [ J ]. Physio Rev, 2002,82(10) :331-3711.
  • 3Ross DT Scherf U, Eisen MB, et al. Systematic variation in gene expression patterns in human cancer cell lines [ J]. Nat Genet, 2000,24 : 227 -235.
  • 4Xin W, Rhodes DR, Ingold C, et al. Dysregulation of the annexin family protein family is associated with prostate cancer progression [ J ]. Am Pathol, 2003,162:255-261.
  • 5Hippo Y, Yashiro M, et al. Differential gene expression profiles of scirrhous gastric cancer cells with high metastatic potential to peritoneum or lymph nodes [ J ]. Cancer Res, 2001, 61:889-895.
  • 6Rosengaarth A, Gerke V , Lueche H. X-ray structure of full-length annexin I and implications for membrane aggregation [ J]. Mol Siol,2001,306( 3 ) :489-g98.
  • 7DreierR, Schmid K W, Gerke V, et al. Differential expression of annexins Ⅰ, Ⅲ and Ⅳ in human tissues:an immunohisto- chemical study [ J ]. Histochem Cell BioI, 1998, 110 ( 2 ) : 137.
  • 8张敏,王金穗,曹云山,李妘,朱任之.膜联蛋白A1的表达差异同乳腺癌发生发展相关性的初步研究[J].实用癌症杂志,2005,20(6):571-574. 被引量:1
  • 9Cicek M, Samant RS, Kinter M, et al. Identification of metastasisassociated proteins through protein analysis of meta- static MDA - MB - 435 and metastasis - suppressed BRMS1 transfected-MDA-MB-435 ceils [ J ]. Clin Exp Metastasis, 2004,21(2) :149-157.
  • 10Smitheman AB, Mohler JL, Maygarden S J, et al . Expression of annexin Ⅰ, Ⅱ and Ⅶ proteins in androgen stimula- ted and recurrent prostate cancer [ J ]. Urol, 2004, 171 (2ptl) :916-920.

二级参考文献1

共引文献131

同被引文献13

  • 1周全超,李毅忠,程静.紫杉醇与顺铂联合介入治疗膀胱癌的疗效观察[J].中国现代医生,2012,45(2):24-25.40.
  • 2Yu E, OSullivan B, Kim J, et al. Magnetic resonance imaging of nasopharyngeal carcinoma[ J]. Exp Rev Ant, 2010, 10(3) :365-375.
  • 3Wong F C, Ng A W, Lee V H, et al. Whole-field simultaneous integrated-boost intensity modulated radiotherapy for patients with nasopharyngeal carcinoma [J]. lnt J Radiat Oncol Biol Phys, 2010, 76 ( 1 ) : 138-145.
  • 4Lee A W M, Tung S Y, Chua D T T, et al. Randomized trial of radiotherapy plus concurrent adjuvant chemotherapy vs radiotherapy alone for regionally advanced nasopharyngeal carcinoma[ J]. J Nat Can Inst, 2010, 102(15) :1188-1192.
  • 5Lin S,Lu J J,Han L,et al. Sequential chemotherapy and intensity modulated radiation therapy in the management of loeoregionally advanced nasopharyngeal carcinoma: experience of 370 consecutive cases [ J 1 . BMC Cancer, 2010,10 ( 1/2 ) :39-44.
  • 6Bonner J A, Harari P M, Giralt J, et al. Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab- induced rash and survival [ J ]. Lancet Oncol, 2010, 11 ( 1 ) :21-28.
  • 7芦东徽,费振乐,郝文胜,牛振阳.鼻咽癌调强放疗与常规放疗的治疗效果与反应的比较[J].安徽医药,2010,14(2):200-202. 被引量:19
  • 8赵充,肖巍魏,韩非,卢丽霞,吴少雄,陈建洲,林承光,黄劭敏,邓小武,卢泰祥,崔念基.419例鼻咽癌患者调强放疗疗效和影响[J].中华放射肿瘤学杂志,2010,19(3):191-196. 被引量:124
  • 9李筱莉,陈燕,叶倩,刘秀琴.EB病毒抗体联合检测在鼻咽癌血清学诊断和筛查中的应用评价[J].检验医学与临床,2011,8(2):140-141. 被引量:15
  • 10李彬燕.鼻咽癌同期放化疗致重度骨髓抑制的护理[J].河北医学,2011,17(1):136-138. 被引量:2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部